Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-11-06
Court District Court, D. Delaware Date Terminated 2016-05-23
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Patents 8,288,434; 8,663,699
Attorneys Jack B. Blumenfeld
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-06 1 United States Patent Nos. 8,288,434 (“the ’434 patent”) and 8,663,699 (“the ’699 patent”) arising under… THE PATENTS IN SUIT 8. The U.S. Patent and Trademark Office (“PTO…PTO”) issued the ’434 patent on October 16, 2012. The ’434 patent claims, inter alia, formulations of…. Dow is the assignee of the ’434 patent. A copy of the ’434 patent is attached hereto as Exhibit A. …. The PTO issued the ’699 patent on March 4, 2014. The ’699 patent claims, inter alia, methods of External link to document
2015-11-06 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,288,434 B2; 8,663,699 B2. (… 2015 23 May 2016 1:15-cv-01030 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.